Genix Pharmaceuticals Corporation
GENX.V
TSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -57.30K | -38.10K | -66.50K | -60.80K | -36.60K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | 200.00 | 200.00 | 200.00 |
| Total Other Non-Cash Items | 45.20K | 20.40K | 41.50K | 30.80K | 22.10K |
| Change in Net Operating Assets | 200.00 | -4.60K | 2.40K | 18.40K | 5.50K |
| Cash from Operations | -11.90K | -22.30K | -22.40K | -11.40K | -8.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 25.00K | -- | 1.10K | 16.00K | 15.40K |
| Total Debt Repaid | -- | -- | -30.00K | -- | -- |
| Issuance of Common Stock | -- | -- | 100.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1.10K | -- | -- |
| Cash from Financing | 18.30K | -- | 50.40K | 11.70K | 10.80K |
| Foreign Exchange rate Adjustments | -7.90K | -- | -- | -- | -1.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.50K | -22.30K | 28.10K | 200.00 | 800.00 |